This Diagnostic Testing Company Down 60% – Time to Buy? Posted byPragya Pandey June 29, 2022 Leave a comment on This Diagnostic Testing Company Down 60% – Time to Buy? Despite witnessing double-digit revenue growth in the last reported quarter Natera Inc. (NTRA) stock has plunged nearly 60% year-to-date. So, let’s evaluate if it is worth buying the stock now….